Manufacturing Manager, Liso-cel CAR-T, Manufacturing Operations at Bristol-Myers Squibb

Summit, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Leads by example and drives team to adhere to BMS values: Inclusion, Accountability, Innovation, Urgency, and Passion
  • Accountable for ensuring Work Centered Team (WCT) executes Cell Therapy manufacturing according to cGMPs, SOPs, and Work Instructions
  • Takes personal responsibility for safety, performs regular safety Gemba walks, knows hazards, demonstrates safe behavior, and operates/maintains equipment to prevent injuries
  • Accountable for Production Records, performs batch record reviews (BRR) or Electronic Batch Record review by exception, ensures ALCOA+ principles, right-first-time documentation, complete/accurate records/logbooks, and resolves errors to meet turnaround times
  • Performs Cell Therapy manufacturing to maintain hands-on expert knowledge of each Unit Operation, demonstrates good execution to new members, and backfills for absent team members to meet production schedules
  • Further develops technical expertise in CAR-T manufacturing requirements
  • Provides Production Scheduling team with daily/weekly/monthly information on WCT production resource availability and tracks actual vs. planned/unplanned absences (holidays, sickness, etc.)
  • Hires personnel meeting job description criteria, BMS values, budgetary, and fiscal requirements
  • Sets WCT priorities and adjusts as necessary
  • Availability for Wednesday - Saturday night shift (5 p.m. - 5:30 a.m., with every other Wednesday off), onsite

Responsibilities

  • Manage and provide oversight of a Work Centered Team (WCT) executing Cell Therapy manufacturing processes
  • Ensure WCT maintains a culture of safety, compliance, innovation, and Continuous Improvement in Manufacturing Operations
  • Report to Senior Manager, Manufacturing
  • Ensure WCT members work safely and adhere to safety practices

Skills

Cell Therapy Manufacturing
GMP Compliance
Continuous Improvement
Safety Management
Team Leadership
Manufacturing Operations
CAR-T Processes

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI